Merck KGaA and Abbisko Therapeutics have announced positive results from a late-stage study of pimicotinib in patients with ...

AstraZeneca (AZ) and Merck – known as MSD outside the US and Canada – have shared positive results from a late-stage study of ...

Patient pathways promise improved treatments and outcomes, yet they often lead to a maze of access, equity and service issues ...

Traditionally, stories include several key elements: characters, setting, plot and an inciting incident to catalyse the rest of the story through climax and resolution. Stories also have causality – ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active moderate-to-severe hidradenitis suppurativa (HS) in adults. Estimated to affect one in ...

The explosive growth of Gen AI has caused plenty of consternation as well as celebration, but there’s no turning back the ...

AstraZeneca (AZ) and Amgen have shared positive results from a late-stage study of Tezspire (tezepelumab) in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The phase 3 WAYPOINT trial ...

The US Food and Drug Administration (FDA) has approved Autolus Therapeutics’ Aucatzyl (obecabtagene autoleucel) to treat acute lymphoblastic leukaemia (ALL). The CD19-directed CAR-T cell therapy has ...

Johnson & Johnson (J&J) has announced that its anti-FcRn antibody nipocalimab has become the first investigational therapy to be granted breakthrough therapy designation (BTD) by the US Food and Drug ...